Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1704 results
T cell

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

by Jacob Smith | Analysis | 11 November 2022

11 November 2022

This entry is part 1 of 10 in the series Diversity in research
%postcontent%
A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022

As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience. As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience.

by Phil Prime | Interview | 12 October 2022

12 October 2022

We hear from the Excellence in Cancer Research Nursing Award shortlisted nurses about their work and the vital role they play in delivering clinical trials... We hear from the Excellence in Cancer Research Nursing Award shortlisted nurses about their work and the vital role they play in delivering clinical trials...

by Phil Prime | In depth | 7 October 2022

7 October 2022

A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact... A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact...

by Phil Prime | Interview | 27 September 2022

27 September 2022

A photo of Katie Currie with her mum and sister

In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early.  In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early. 

by Lilly Matson | Analysis | 16 September 2022

16 September 2022

A prostate cancer cell.

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

by Jacob Smith | News | 13 September 2022

13 September 2022

A woman sat on a sofa looking into the distance

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it? A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

by Jacob Smith | In depth | 10 August 2022

10 August 2022